- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00477399
Long Term Follow up After 1 Year Initial Lifestyle Intervention
Effect of Four Years Intensive- Versus Regular Follow up, After a One Year Weight Loss Period, in Patients With Morbid Obesity.
The effect of non-surgical methods for obesity treatment are not fully documented. This study focus on the long term effect of an intensiv follow up (the "Evje Model") compared to a regular follow up.
The "Evje Model" is a combined model, consisting of repeated stays at a specialist centre, telephone follow up at home, home groups, self monitoring and close contact with the patients' local physician.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
200 patients will undergo a 1 year intensive lifestyle intervention.This group will be randomised into an intervention group (n=100) and a control group (n=100). The intervention group will undergo four years of further follow up in accordance with the intervention model, which means two one weeks stays each year at the Evje Clinic, telephone follow up, self monitoring and collaboration with the patients' local physician.
The control group will be followed up by the patients local physician and a yearly control at the Center for Morbid Obesity at Vestfold Hospital (Sykehuset i Vestfold HF).
The purpose is to measure the effect of these two follow up models in regard to weight loss maintanance, Quality of Life and comorbidities.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Evjemoen
-
Evje, Evjemoen, Norway, 4735
- Evjeklinikken AS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients, referred from Public Hospitals, with morbid obesity that have undergone one year intensive life style intervention in accordance with the Evje Model.
Exclusion Criteria:
- Pregnancy, major and active psychiatric disease, active and serious eating disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Control group
|
|
|
Other: Intervention
Receiving active follow up (two yearly 1 week stays, telephone follow up, GP-visits)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Weight loss
Time Frame: 03.2015
|
03.2015
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Health related quality of life
Time Frame: 03.2015
|
03.2015
|
|
Anthropometrics
Time Frame: 03.2015
|
03.2015
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Joran Hjelmesath, Dr. Med., Sykehuset I Vestfold HF
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK0701
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Long term follow up after intensive lifestyle intervention
-
Ukraine Association of BiobankActive, not recruitingDiabete Type 2 | Mesenchymal Stem CellUkraine
-
City of Hope Medical CenterActive, not recruiting
-
Blue Note TherapeuticsEnrolling by invitation
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Myeloid Leukemia (AML) | Pediatric Acute Myeloid Leukemia
-
Shandong UniversityRecruitingPolycystic Ovary SyndromeChina, United States, Brazil, Singapore, Sweden, Turkey
-
Miltenyi Biomedicine GmbHRecruiting
-
Calibr, a division of Scripps ResearchEnrolling by invitation
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Princesse GraceCompletedFamily Caregivers | Alzheimer's Dementia (AD)Monaco
-
Abbott Medical DevicesCompletedAdvanced Refractory Left Ventricular Heart FailureGermany, Canada, Austria, Czechia, Kazakhstan, Australia
-
REGENXBIO Inc.Enrolling by invitation